To examine the post-transcriptional mechanism by which ELAVL2 regulates SH3GL3 and DNM3, we first examined the mRNA half-life of SH3GL3 and DNM3 in both ELAVL2-depleted and ELAVL2-high GBM cells. The gene discussed is SH3GL3; the disease is glioblastoma.